Wordt geladen...
Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
Glioblastoma multiforme (GBM) is the most common and malignant primary intracranial tumor, and has a median survival of only 10 to 14 months with only 3 to 5% of patients surviving more than three years. Recurrence (RGBM) is nearly universal, and further decreases the median survival to only five to...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3514151/ https://ncbi.nlm.nih.gov/pubmed/23095807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-10-220 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|